Aryl substituted bicyclic amines as selective dopamine D3 ligands
申请人:Pharmacia & Upjohn Company
公开号:US06084130A1
公开(公告)日:2000-07-04
Compounds and their pharmaceutically acceptable salts suitable for treating central nervous system disorders associated with the dopamine D3 receptor activity of structural Formula I: ##STR1##